Lawrence M. Scheier, Ph.D. is Adjunct Professor in the Department of Psychiatry at Washington University School of Medicine, St. Louis. Dr. Scheier is also President of LARS Research Institute, a Nevada-based non-profit company offering a full line of services in program development, evaluation, technology transfer, and health promotion especially among youthful populations. Dr. Scheier received his Ph.D. from the University of Southern California in 1988, completed an NIAAA postdoctoral fellowship at the Alcohol Research Group, University of California, Berkeley, and also an NIMH postdoctoral fellowship in developmental studies at the Polisher Research Institute, Philadelphia Geriatric Center, Medical College of Pennsylvania. Dr. Scheier has used his training and methodological expertise to work with a variety of groups developing longitudinal models of health, drug etiology and drug consequences and he has published with noted luminaries in the drug abuse field including Drs. Peter Bentler, Michael Newcomb, Denise Kandel, Linda Cottler, and Gilbert Botvin.
Dr. Scheier has been a Principal Investigator on several federally funded grants from the National Institute on Drug Abuse, specifically emphasizing evaluation of school-based drug abuse prevention programs, longitudinal studies of adolescent drug etiology and drug consequences, and more recently studies of social cognition and identity formation in multiracial youth. His particular interest rests with studies of cognitive efficacy, mastery, and control in an effort to determine whether drug use disrupts development and has deleterious consequences on young adult functioning. Dr. Scheier is well versed in causal modeling techniques, growth curve analysis, and multivariate statistical methods for application in developmental health studies. Dr. Scheier is currently a member of the editorial board of four prominent drug studies journals including the Journal of Alcohol and Drug Education, Journal of Drug Education, Journal of Studies on Alcohol, and Journal of Child and Adolescent Substance Abuse. Dr. Scheier has participated as a reviewer for NIAAA, NIMH, and NIDA and most recently was a member of a NIH special emphasis panel emphasizing prevention methodology (Social Sciences, Nursing, Epidemiology, and Methods Integrated Review Group [SNEM-1]) and NIDA-K for training and career research awards.